First Posted 11/14/2013 I received an email update today with important news from the world of psychiatry and addiction. The email highlighted a study from the October issue of Jama Psychiatry, entitled ‘A Randomized, Double-blind Evaluation of Buprenorphine Taper Duration in Primary Prescription Opioid Abusers’. The study compared relapse rates in Read more…
Today I met with representatives from Alkermes who were promoting Vivitrol, a long-acting mu opioid antagonist that is indicated for treatment of alcoholism and opioid dependence. I admit to some pre-existing bias against the medication. I’m not certain, to be honest, whether that bias was based upon sound clinical reasoning, Read more…
Oxycontin was not my drug of choice so I don’t know the ins and outs of abusing the medication. But I suppose anything that makes the drug harder to abuse is a good thing. The other things that are being looked at for approval are combinations of agonist with antagonist Read more…
I am going to share an interaction with a person who wrote to me about using the Naltrexone implant. I am always a bit suspicious about the motivations of people who want comments posted about a different type of treatment, or who come with pot-shots against Suboxone. I don’t go Read more…
I encourage addicts doing the work of staying clean to ‘bring the memory full circle’; with every pleasant recollection, be sure to think about where the use took you, and where the pleasant sensations ended.
thank you anyway for replying.. So when i do get into seeing a doctor, i must be in withdrawal? I am so confused on this issue. I am taking suboxone, but most likely have to take the lortab when it is out of my system because of the pain i do Read more…